Monographie - Topotecan - Stabilis 4.0

Ultimo aggiornamento :
08/05/2024

Farmaco contro il cancro

Topotecan

Iniezione

Stabilità in soluzione

Stabilità in miscela

Fattori che influenzano la stabilità

Compatibilità

Metodo di iniezione

Bibliografia

Pdf

Struttura chimica

Nome commerciale

Nome commerciale

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Acumil	Messico
Camtoop	Messico
Cantop	India
Hycamtin	Arabia Saudita, Australia, Austria, Belgio, Brasile, Canada, Chile, Colombia, Danimarca, Ecuador, Egitto, Emirati Arabi Uniti, Finlandia, Francia, Germania, Giappone, Gran Bretagna, Grecia, Irlanda, Islanda, Italia, Lussemburgo, Malaysia, Norvegia, Paesi Bassi, Polonia, Portogallo, Spagna, Stati Uniti d’America, Svezia, Svizzera, Turchia, Ungheria, Venezuela
Oncotecan	Colombia, Ecuador
Potactasol	Argentina, Belgio, Germania, Norvegia, Romania
Tekan L	Turchia
Topodria	Colombia
Topokebir	Argentina, Perù
Toposec	Perù
Topotecan	Belgio, Canada, Colombia, Germania, Gran Bretagna, Norvegia, Perù, Romania, Spagna
Topotel	Egitto
Toranex	Messico
Tpopoxin	Turchia
Viatopin	Ungheria

Bibliografia

Iniezione

Bibliografia : Topotecan

	Tipo	Pubblicazione
753	Laboratorio	Topotecan (Topotecan Hospira®) - Summary of Product Characteristics Hospira 2016
823	Rivista	Patel K, Craig SB, McBride MG, Palepu NR. Microbial inhibitory properties and stability of topotecan hydrochloride injection. Am J Health-Syst Pharm 1998 ; 55: 1584-1587.
1026	Rivista	Mayron D, Gennaro AR. Stability and compatibility of topotecan hydrochloride with selected drugs. Am J Health-Syst Pharm 1999 ; 56: 875-881.
1075	Rivista	Craig SB, Bhatt UH, Patel K. Stability and compatibility of topotecan hydrochloride for injection with common infusion solutions and containers. J Pharm Biomed Anal 1997 ; 16: 199-205.
1274	Rivista	Krämer I, Thiesen J. Pharmazeutische aspekte von topotecan-infusionen. TAP Pharmazeutische Zeitung 1997 ; 31: 30-33.
1423	Rivista	Trissel LA, Martinez JF, Gilbert DL. Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection. J Am Pharm Assoc 1999 ; 39: 514-518.
1425	Rivista	Krämer I, Thiesen J. Stability of topotecan infusion solutions in polyvinylchloride bags and elastomeric portable infusion devices. J Oncol Pharm Practice 1999 ; 5: 75-82.
1662	Rivista	Trissel LA, Saenz CA, Ingram DS, Ogundele AB. Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs. J Oncol Pharm Practice 2002 ; 8: 33-37.
1953	Rivista	Trissel LA, Saenz CA, Ogundele AB, Ingram DS. Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
1976	Rivista	Trissel LA, Xu QA. Physical and chemical stability of palonosetron hydrochloride with topotecan hydrochloride and irinotecan hydrochloride during simulated Y-site administration. Int J Pharm Compound 2005 ; 9, 3: 238-241.

Mentions Légales